GLG LLC’s Allergan plc AGN.PRA Stock Holding History

GLG LLC’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,840	Closed	-$1.53M	–	548
2016 Q2	$1.53M	Buy	+1,840	New	+$1.54M	0.12%	199

Other funds holding AGN.PRA

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

GLG LLC's AGN.PRA Position: Q3 2016 in Review

GLG LLC sold out of Allergan plc (AGN.PRA) in Q3 2016, closing a stake of 1,840 shares — an estimated $1.53M sold.

GLG LLC first reported a position in AGN.PRA in Q2 2016 and held it in 1 quarter. The position peaked at $1.53M in Q2 2016. 117 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2016.

GLG LLC reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
GLG LLC sold 1,840 Allergan plc shares in Q3 2016, an estimated $1.53M.
GLG LLC first reported a position in Allergan plc in Q2 2016 and held it in 1 quarter.
GLG LLC's Allergan plc position peaked at $1.53M in Q2 2016.
117 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on GLG LLC's 13F filing for Q3 2016, filed 14 Nov 2016.